{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670319291177600.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.nano.2013.01.009"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1549963413000154?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1549963413000154?httpAccept=text/plain"}}],"dc:title":[{"@value":"An efficient, chemically-defined semisynthetic lipid-adjuvanted nanoparticulate vaccine development system"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670319291177731","@type":"Researcher","foaf:name":[{"@value":"Peter M. Moyle"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319291177730","@type":"Researcher","foaf:name":[{"@value":"Jon Hartas"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319291177601","@type":"Researcher","foaf:name":[{"@value":"Anna Henningham"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319291177600","@type":"Researcher","foaf:name":[{"@value":"Michael R. Batzloff"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319291177729","@type":"Researcher","foaf:name":[{"@value":"Michael F. Good"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319291177728","@type":"Researcher","foaf:name":[{"@value":"Istvan Toth"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"15499634"}],"prism:publicationName":[{"@value":"Nanomedicine: Nanotechnology, Biology and Medicine"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2013-10","prism:volume":"9","prism:number":"7","prism:startingPage":"935","prism:endingPage":"944"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1549963413000154?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S1549963413000154?httpAccept=text/plain"}],"createdAt":"2013-02-19","modifiedAt":"2020-03-13","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360853567370300800","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Lipid Nanoparticle Acts as a Potential Adjuvant for Influenza Split Vaccine without Inducing Inflammatory Responses"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.nano.2013.01.009"},{"@type":"CROSSREF","@value":"10.3390/vaccines8030433_references_DOI_CSQd821hhMXrPheLlaTxI3m2cNn"}]}